Clinical factors, but not C-reactive protein, predict progression of calcific aortic-valve disease: The cardiovascular health study

被引:160
作者
Novaro, Gian M.
Katz, Ronit
Aviles, Ronnier J.
Gottdiener, John S.
Cushman, Mary
Psaty, Bruce M.
Otto, Catherine M.
Griffin, Brian P.
机构
[1] Cleveland Clin Florida, Dept Cardiol, Weston, FL 33331 USA
[2] Univ Washington, Dept Biostat, Seattle, WA 98195 USA
[3] Overlake Hosp Med Ctr, Bellevue, WA USA
[4] Univ Maryland, Sch Med, Div Cardiol, Baltimore, MD 21201 USA
[5] Univ Vermont, Dept Med, Colchester, VT 05405 USA
[6] Univ Washington, Dept Med, Seattle, WA USA
[7] Univ Washington, Dept Epidemiol & Hlth Serv, Seattle, WA USA
[8] Univ Washington, Dept Cardiol, Seattle, WA 98195 USA
[9] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44106 USA
关键词
D O I
10.1016/j.jacc.2007.07.064
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives The purpose of this study was to examine the relationship between C-reactive protein (CRP) and calcific aortic valve disease in a large, randomly selected, population-based cohort. Background The pathobiology of calcific aortic stenosis involves an active inflammatory, atheromatous, osteogenic process. Elevations in CRP, a measure of systemic inflammation, have been associated with aortic stenosis. Methods Two-dimensional and Doppler echocardiography and CRP measurement were performed at baseline in 5,621 participants in the Cardiovascular Health Study. Multivariable analysis was used to identify CRP as a predictor of baseline and incident aortic stenosis. Results At a mean echocardiographic follow-up of 5 years, 9% of subjects with aortic sclerosis progressed to some degree of aortic stenosis. Increasing age (odds ratio [OR] 1.13, 95% confidence interval [CI] 1.09 to 1.16; p < 0.001) and male gender (OR 3.05, 95% Cl 1.76 to 5.27; p < 0.001) were related to risk of incident aortic stenosis, whereas increasing height (OR 0.96, 95% Cl 0.94 to 0.99; p = 0.013) and African-American ethnicity conveyed a lower risk (OR 0.49, 95% Cl 0.25 to 0.95; p = 0.035). C-reactive protein, treated as a continuous variable, was not associated with baseline aortic stenosis, progression to aortic sclerosis (adjusted OR 0.93, 95% Cl 0.85 to 1.02; p = 0.107), or progression to aortic stenosis (adjusted OR 0.85, 95% Cl 0.70 to 1.03; p = 0.092). Conclusions In this large population-based cohort, approximately 9% of subjects with aortic sclerosis progressed to aortic stenosis over a 5-year follow-up period. There was no association between CRP levels and the presence of calcific aortic-valve disease or incident aortic stenosis. C-reactive protein appears to be a poor predictor of subclinical calcific aortic-valve disease. (J Am Coll Cardiol 2007;50:1992-9) (c) 2007 by the American College of Cardiology Foundation.
引用
收藏
页码:1992 / 1998
页数:7
相关论文
共 36 条
[1]   Aortic valve sclerosis is associated with preclinical cardiovascular disease in hypertensive adults: the Hypertension Genetic Epidemiology Network study [J].
Agno, FS ;
Chinali, M ;
Bella, JN ;
Liu, JE ;
Arnett, DK ;
Kitzman, DW ;
Oberman, A ;
Hopkins, PN ;
Rao, DC ;
Devereux, RB .
JOURNAL OF HYPERTENSION, 2005, 23 (04) :867-873
[2]   Risk for osteoporosis in black women [J].
Aloia, JF ;
Vaswani, A ;
Yeh, JK ;
Flaster, E .
CALCIFIED TISSUE INTERNATIONAL, 1996, 59 (06) :415-423
[3]   CORRELATION OF SERUM-LIPIDS, CALCIUM, AND PHOSPHORUS, DIABETES-MELLITUS AND HISTORY OF SYSTEMIC HYPERTENSION WITH PRESENCE OR ABSENCE OF CALCIFIED OR THICKENED AORTIC CUSPS OR ROOT IN ELDERLY PATIENTS [J].
ARONOW, WS ;
SCHWARTZ, KS ;
KOENIGSBERG, M .
AMERICAN JOURNAL OF CARDIOLOGY, 1987, 59 (09) :998-999
[4]   The relation of markers of inflammation to the development of glucose disorders in the elderly - The cardiovascular health study [J].
Barzilay, JI ;
Abraham, L ;
Heckbert, SR ;
Cushman, M ;
Kuller, LH ;
Resnick, HE ;
Tracy, RP .
DIABETES, 2001, 50 (10) :2384-2389
[5]   Ethnic differences in coronary calcification - The multi-ethnic study of atherosclerosis (MESA) [J].
Bild, DE ;
Detrano, R ;
Peterson, D ;
Guerci, A ;
Liu, K ;
Shahar, E ;
Ouyang, P ;
Jackson, S ;
Saad, MF .
CIRCULATION, 2005, 111 (10) :1313-1320
[6]   Cardiac valve calcification: characteristics of patients with calcification of the mitral annulus or aortic valve [J].
Boon, A ;
Cheriex, E ;
Lodder, J ;
Kessels, F .
HEART, 1997, 78 (05) :472-474
[7]   Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation [J].
Caira, FC ;
Stock, SR ;
Gleason, TG ;
McGee, EC ;
Huang, J ;
Bonow, RO ;
Spelsberg, TC ;
McCarthy, PM ;
Rahimtoola, SH ;
Rajamannan, NM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (08) :1707-1712
[8]   The risk of the development of aortic stenosis in patients with "benign" aortic valve thickening [J].
Cosmi, JE ;
Kort, S ;
Tunick, PA ;
Rosenzweig, BP ;
Freedberg, RS ;
Katz, ES ;
Applebaum, RM ;
Kronzon, I .
ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (20) :2345-2347
[9]   C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease [J].
Danesh, J ;
Wheeler, JG ;
Hirschfield, GM ;
Eda, S ;
Eiriksdottir, G ;
Rumley, A ;
Lowe, GDO ;
Pepys, MB ;
Gudnason, V .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (14) :1387-1397
[10]   DIABETES AND HYPERCHOLESTEROLEMIA AMONG PATIENTS WITH CALCIFIC AORTIC-STENOSIS [J].
DEUTSCHER, S ;
ROCKETTE, HE ;
KRISHNASWAMI, V .
JOURNAL OF CHRONIC DISEASES, 1984, 37 (05) :407-415